Article
Plasma SGIP1 methylation in diagnosis and prognosis prediction in hepatocellular carcinoma
4 Nov 2020
Abstract excerpt
Aberrant methylation of some genes can serve as promising biomarkers in hepatocellular carcinoma (HCC). This study aimed to investigate the diagnostic and prognostic value of plasma SGIP1 methylation in HCC. The study included a total of 269 subjects, of which 129 were with HCC, 45 with liver cirrhosis (LC), 45 with chronic hepatitis B (CHB), and 50 were healthy controls (HCs). The aberrant methylation was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
